The efficacy and safety of docetaxel plus thalidomide vs. docetaxel alone in patients with androgen-independent prostate cancer: a systematic review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep04818.pdf
Reference17 articles.
1. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J Clin 63, 11–30, 10.3322/caac.21166 (2013).
2. Petrylak, D. Therapeutic options in androgen-independent prostate cancer: building on docetaxel. BJU Int 96 Suppl 2, 41–46, 10.1111/j.1464-410X.2005.05946.x (2005).
3. Sharifi, N., Gulley, J. L. & Dahut, W. L. Androgen deprivation therapy for prostate cancer. JAMA 294, 238–244, 10.1001/jama.294.2.238 (2005).
4. Oh, W. K., Tully, P., Kantoff, P. W. & Regan, M. M. Physician attitudes toward cytotoxic chemotherapy use in patients with advanced prostate carcinoma. Cancer 97, 2171–2179, 10.1002/cncr.11344 (2003).
5. Oh, W. K. Chemotherapy for patients with advanced prostate carcinoma: a new option for therapy. Cancer 88, 3015–3021 (2000).
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunotoxins and Their Role in Prostate Cancer Treatment;Clinical Cancer Investigation Journal;2023
2. Synergistic effects of thalidomide and cisplatin are mediated via the PI3K/AKT and JAK1/STAT3 signaling pathways in cervical cancer;Oncology Reports;2022-08-02
3. Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open‐label, randomized controlled trial;Cancer;2021-12-15
4. Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin;Journal of Experimental & Clinical Cancer Research;2019-10-28
5. Fabrication of novel combinatorial drug encapsulated micelles for enhanced tumor targeting in intestinal cancer in mouse model;Journal of Cellular Physiology;2019-01-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3